These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6316294)

  • 1. Peptide E and other proenkephalin-derived peptides are potent kappa opiate receptor agonists.
    Quirion R; Weiss AS
    Peptides; 1983; 4(4):445-9. PubMed ID: 6316294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid activity of pro-enkephalin-derived peptides in mouse vas deferens and guinea pig ileum.
    Sánchez-Blázquez P; Garzón J
    Neurosci Lett; 1985 Nov; 61(3):267-71. PubMed ID: 3001596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proenkephalin A-derived peptide E and its fragments alter opioid contractility in the small intestine.
    Davis TP; Hoyer GL; Davis P; Burks TF
    Eur J Pharmacol; 1990 Dec; 191(3):253-61. PubMed ID: 2086244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel opioid peptide, leumorphin, acts as an agonist at the kappa opiate receptor.
    Suda M; Nakao K; Yoshimasa T; Ikeda Y; Sakamoto M; Yanaihara N; Numa S; Imura H
    Life Sci; 1983 Jun; 32(24):2769-75. PubMed ID: 6134225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the action of putative endogenous kappa-agonists, leumorphin and rimorphin in vitro.
    Suda M; Nakao K; Yoshimasa T; Ikeda Y; Sakamoto M; Yanaihara C; Yanaihara N; Numa S; Imura H
    Life Sci; 1983; 33 Suppl 1():275-8. PubMed ID: 6319876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacological profile of BAM 18.
    Hurlbut DE; Evans CJ; Barchas JD; Leslie FM
    NIDA Res Monogr; 1986; 75():81-4. PubMed ID: 2829012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that endogenous 6-(ARG or LYS)-opioid peptides can interact with kappa-receptors as agonists.
    Oka T; Negishi K
    Life Sci; 1982 Oct 18-25; 31(16-17):1707-10. PubMed ID: 6130430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of a proenkephalin A-derived opioid peptide: BAM 18.
    Hurlbut DE; Evans CJ; Barchas JD; Leslie FM
    Eur J Pharmacol; 1987 Jun; 138(3):359-66. PubMed ID: 3040439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor.
    Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Paterson SJ; Robson LE
    Br J Pharmacol; 1984 Sep; 83(1):271-9. PubMed ID: 6091824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
    Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
    Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue content of opioid peptides in the myenteric plexus-longitudinal muscle of guinea-pig small intestine.
    Corbett AD; McKnight AT; Kosterlitz HW
    J Neurochem; 1988 Jul; 51(1):32-7. PubMed ID: 3379412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leumorphin is a potent, kappa opioid receptor agonist.
    Suda M; Nakao K; Yoshimasa T; Sakamoto M; Morii N; Ikeda Y; Yanaihara C; Yanaihara N; Numa S; Imura H
    Neurosci Lett; 1984 Sep; 50(1-3):49-52. PubMed ID: 6149506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioligands for probing opioid receptors.
    Paterson SJ; Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Robson LE
    J Recept Res; 1984; 4(1-6):143-54. PubMed ID: 6098650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
    Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine substitution increases mu-selectivity of potent di- and tri-peptide enkephalin analogs.
    Vavrek RJ; Cui RL; York EJ; Stewart JM; Paterson S; Kosterlitz HW
    Life Sci; 1983; 33 Suppl 1():451-4. PubMed ID: 6319902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The choice of opiate receptor subtype by neo-endorphins.
    Oka T; Negishi K; Kajiwara M; Watanabe Y; Ishizuka Y; Matsumiya T
    Eur J Pharmacol; 1982 Apr; 79(3-4):301-5. PubMed ID: 6284522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate activity of peptides derived from the three opioid peptide families on the rat vas deferens.
    Sánchez-Blázquez P; Garzón J; Lee NM; Höllt V
    Neuropeptides; 1984 Dec; 5(1-3):181-4. PubMed ID: 6099492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proenkephalin A fragment, peptide E: central processing and CNS activity in vivo.
    Davis TP; Porreca F; Burks TF; Dray A
    Eur J Pharmacol; 1985 May; 111(2):177-83. PubMed ID: 2990950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new family of endogenous "big" Met-enkephalins from bovine adrenal medulla: purification and structure of docosa- (BAM-22P) and eicosapeptide (BAM-20P) with very potent opiate activity.
    Mizuno K; Minamino N; Kangawa K; Matsuo H
    Biochem Biophys Res Commun; 1980 Dec; 97(4):1283-90. PubMed ID: 7213356
    [No Abstract]   [Full Text] [Related]  

  • 20. K receptor activities of the three opioid peptide families.
    Rezvani A; Höllt V; Way EL
    Life Sci; 1983; 33 Suppl 1():271-4. PubMed ID: 6319875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.